Last year, Baltimore had three mass overdose incidents in the span of three months in its Penn North neighborhood. In one incident, more than two dozen people were hospitalized after many were found unresponsive, lying in the streets or on sidewalks. No one died, but some came close. Follow-up testing found that the street drugs…
HOT SPRINGS, S.D. — Two of the nation’s most powerful health officials predict artificial intelligence will play a key role in solving rural America’s health challenges. Health secretary Robert F. Kennedy Jr. told a panel of U.S. senators that AI nurses can provide “concierge care” to rural patients. Mehmet Oz, who leads the Centers for…
By MATTHEW HOLT Strap in for the tale of why your hero is spending most of his life down YouTube rabbit holes of cardiology videos while blundering his way around many many medical centers and exposing many problems with American health care even before he gets close to the operating table. Yes it’s Matthew Holt’s…
CMS unveiled new details of its new RAPID pathway, which is designed to close the gap between FDA approval and Medicare coverage for breakthrough medical devices. Industry reaction has been largely positive, as medical device companies often sit in “coverage purgatory” for years. The post How CMS Is Tackling ‘Coverage Purgatory’ for Medical Devices appeared…
Tanvi Patel, vice president and general manager of Amazon Pharmacy, and her co-panelists at the recent Bullseye event, explained why PBMs, payers and doctors are all hampering consumer choice when it comes to patients getting affordable drugs. The post Amazon Pharmacy Executive: Formularies are Anti-Choice appeared first on MedCity News.
Small group insurers are proposing a median 14% premium increase for 2027, driven by rising healthcare costs. The post Small Businesses Could Face Double-Digit Premium Hikes in 2027 appeared first on MedCity News.
Jazz Pharmaceuticals, maker of the blockbuster epilepsy drug Epidiolex, is acquiring Actio Biosciences and its lead drug in pivotal testing for a rare type of epilepsy with no FDA-approved treatments. It’s Jazz’s second epilepsy deal in the past year. The post Jazz Pharma Expands Again in Epilepsy With $850M Actio Bio Acquisition appeared first on…
In this episode of the MedCity Pivot Podcast, CVS Health Aetna’s chief digital and technology officer talks about how the insurance business is using AI, especially agentic AI, in healthcare. Point to note: AI is not used in automatic denials of coverage. The post MedCity Pivot: How Aetna is Adopting Agentic AI appeared first on…
Drug development isn’t limited by the amount of data we collect, but by our ability to preserve the context, meaning and relationships that transform data into evidence. The post AI in Drug Development is Not a Data Problem — It’s An Evidence Problem appeared first on MedCity News.
Ascension is pushing AI beyond note-taking to tackle the billing, order entry and nursing handoff work still weighing on clinicians after a patient visit ends. The post How to Keep Clinicians Satisfied, the Ascension Way appeared first on MedCity News.